BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3064079)

  • 1. Amino acid sequence of guinea pig C3a anaphylatoxin.
    Gerard NP; Lively MO; Gerard C
    Protein Seq Data Anal; 1988; 1(6):473-8. PubMed ID: 3064079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The primary structure of porcine C3a anaphylatoxin.
    Corbin NC; Hugli TE
    J Immunol; 1976 Sep; 117(3):990-5. PubMed ID: 956663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification, characterization, and amino acid sequence of rat anaphylatoxin (C3a).
    Jacobs JW; Rubin JS; Hugli TE; Bogardt RA; Mariz IK; Daniels JS; Daughaday WH; Bradshaw RA
    Biochemistry; 1978 Nov; 17(23):5031-8. PubMed ID: 309768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y; Hugli TE
    J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.
    Fukuoka Y; Ember JA; Hugli TE
    J Immunol; 1998 Sep; 161(6):2977-84. PubMed ID: 9743361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
    Meuer S; Becker S; Hadding U; Bitter-Suermann D
    Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):135-46. PubMed ID: 77089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
    Fukuoka Y; Hugli TE
    J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third component of trout complement. cDNA cloning and conservation of functional sites.
    Lambris JD; Lao Z; Pang J; Alsenz J
    J Immunol; 1993 Dec; 151(11):6123-34. PubMed ID: 8245455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and partial characterization of human and porcine C3a anaphylatoxin.
    Hugli TE; Vallota EH; Müller-Eberhard HJ
    J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The active site of human C4a anaphylatoxin.
    Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and crystallization of human anaphylatoxin, C3a.
    Pâques EP; Scholze H; Huber R
    Hoppe Seylers Z Physiol Chem; 1980; 361(6):977-80. PubMed ID: 7399418
    [No Abstract]   [Full Text] [Related]  

  • 13. Generation, purification and functional characterization of three C3a anaphylatoxins in rainbow trout: role in leukocyte chemotaxis and respiratory burst.
    Rotllant J; Parra D; Peters R; Boshra H; Sunyer JO
    Dev Comp Immunol; 2004 Jun; 28(7-8):815-28. PubMed ID: 15043949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.
    Fernandez HN; Hugli TE
    J Immunol; 1976 Nov; 117(5 Pt 1):1688-94. PubMed ID: 1002996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74.
    Gerard C; Showell HJ; Hoeprich PD; Hugli TE; Stimler NP
    J Biol Chem; 1985 Mar; 260(5):2613-6. PubMed ID: 3972798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of bovine complement component C3 and its cleavage products.
    Di Carlo AL; Paape MJ; Hellman J; Lilius EM
    Am J Vet Res; 1997 Jun; 58(6):585-9. PubMed ID: 9185962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
    Burger R; Zilow G; Bader A; Friedlein A; Naser W
    J Immunol; 1988 Jul; 141(2):553-8. PubMed ID: 2454995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
    Stimler NP; Bach MK; Bloor CM; Hugli TE
    J Immunol; 1982 May; 128(5):2247-52. PubMed ID: 6174625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and partial amino acid sequence of human aconitase.
    Baldwin GS; Seet KL; Callaghan J; Toncich G; Toh BH; Moritz RL; Rubira MR; Simpson R
    Protein Seq Data Anal; 1991 Aug; 4(2):63-7. PubMed ID: 1946331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.